NURS 318 EXAM 3 ( 2026-2027) QUESTIONS
AND ANSWERS GRADED A+
which drugs would cause a decrease in heparin effects? SATA
a. Nitroglycerin
b. protamine sulfate
c. NSAIDS
d. antibiotics
e. SSRI
a. Nitroglycerin
b. protamine sulfate (ANTIDOTE)
What is a common side effect of heparin?
a. Anaphylaxis
b. injection site reaction
c. increased bleeding
d. anemia
b. injection site reaction
,what are some adverse effects heparin can cause? SATA
a. bleeding
b. anemia
c. itching
d. chills
e stroke
f. elevated hepatic enzymes
f. elevated hepatic enzymes
a. bleeding
b. anemia
e stroke
what is a life threatening effect from heparin? SATA
a. hemorrhage
b. heparin-induced thrombocytopenia
c. stroke
d. bleding
e. anemia
a. hemorrhage
b. heparin-induced thrombocytopenia
,which assessment should be done before a patient begins heparin?
a. Obtain history of abnormal clotting or health problems that affect clotting
b. Monitor INR and platelet counts
c. Observe for s/s of active bleeding. Antidote - aminocaproic acid
d. Monitor for bleeding - mouth, stool, urine and skin
a. Obtain history of abnormal clotting or health problems that affect clotting
all others are interventions
which nursing intervention will the nurse FIRST take BEFORE administering
heparin?
a. Monitor PTT/aPTT
b. Monitor platelet counts
c. Monitor for bleeding
d.Keep antidote available
a. Monitor PTT/aPTT
other interventions include those but are not done BEFORE admin
make sure to monitor Vital Signs as well
what is the prototype drug for low Molecular-Weight Heparin?
a. enoxaparin (Lovenox)
b. warfarin
c. clopidrogel
, d. alteplase
a. enoxaparin (Lovenox)
if a pt is experienced an acute MI, which drug would the nurse anticipate the PCP
to administer for prophylaxis reasons?
a. enoxaparin (Lovenox)
b. warfarin
c. heparin
d. alteplase
a. enoxaparin (Lovenox)
used
what is the MOA for low Molecular-Weight Heparin?
a. Inhibits factor Xa by increasing inhibition rate of clotting activated by
antithrombin III
b. Depresses hepatic synthesis of vitamin K clotting factors
c. Inhibits platelet aggregation and prevent ADP (adenosine diphosphate) from
binding with the ADP platelet receptors
d. clot buster
a. Inhibits factor Xa by increasing inhibition rate of clotting activated by
antithrombin III
AND ANSWERS GRADED A+
which drugs would cause a decrease in heparin effects? SATA
a. Nitroglycerin
b. protamine sulfate
c. NSAIDS
d. antibiotics
e. SSRI
a. Nitroglycerin
b. protamine sulfate (ANTIDOTE)
What is a common side effect of heparin?
a. Anaphylaxis
b. injection site reaction
c. increased bleeding
d. anemia
b. injection site reaction
,what are some adverse effects heparin can cause? SATA
a. bleeding
b. anemia
c. itching
d. chills
e stroke
f. elevated hepatic enzymes
f. elevated hepatic enzymes
a. bleeding
b. anemia
e stroke
what is a life threatening effect from heparin? SATA
a. hemorrhage
b. heparin-induced thrombocytopenia
c. stroke
d. bleding
e. anemia
a. hemorrhage
b. heparin-induced thrombocytopenia
,which assessment should be done before a patient begins heparin?
a. Obtain history of abnormal clotting or health problems that affect clotting
b. Monitor INR and platelet counts
c. Observe for s/s of active bleeding. Antidote - aminocaproic acid
d. Monitor for bleeding - mouth, stool, urine and skin
a. Obtain history of abnormal clotting or health problems that affect clotting
all others are interventions
which nursing intervention will the nurse FIRST take BEFORE administering
heparin?
a. Monitor PTT/aPTT
b. Monitor platelet counts
c. Monitor for bleeding
d.Keep antidote available
a. Monitor PTT/aPTT
other interventions include those but are not done BEFORE admin
make sure to monitor Vital Signs as well
what is the prototype drug for low Molecular-Weight Heparin?
a. enoxaparin (Lovenox)
b. warfarin
c. clopidrogel
, d. alteplase
a. enoxaparin (Lovenox)
if a pt is experienced an acute MI, which drug would the nurse anticipate the PCP
to administer for prophylaxis reasons?
a. enoxaparin (Lovenox)
b. warfarin
c. heparin
d. alteplase
a. enoxaparin (Lovenox)
used
what is the MOA for low Molecular-Weight Heparin?
a. Inhibits factor Xa by increasing inhibition rate of clotting activated by
antithrombin III
b. Depresses hepatic synthesis of vitamin K clotting factors
c. Inhibits platelet aggregation and prevent ADP (adenosine diphosphate) from
binding with the ADP platelet receptors
d. clot buster
a. Inhibits factor Xa by increasing inhibition rate of clotting activated by
antithrombin III
